By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics, Inc. (HTGMQ)

OTC Currency in USD
$0.00
$0.00
0.00%
Last Update: 29 Aug 2025, 00:00
$221.00
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.01
52 Week Range

HTGMQ Stock Price Chart

Explore HTG Molecular Diagnostics, Inc. interactive price chart. Choose custom timeframes to analyze HTGMQ price movements and trends.

HTGMQ Company Profile

Discover essential business fundamentals and corporate details for HTG Molecular Diagnostics, Inc. (HTGMQ) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

IPO Date

6 May 2015

Employees

53.00

CEO

John L. Lubniewski

Description

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq Oncology Biomarker Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona. On June 5, 2023, HTG Molecular Diagnostics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

HTGMQ Financial Timeline

Browse a chronological timeline of HTG Molecular Diagnostics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 31 Dec 2024

Earnings released on 23 Dec 2024

Earnings released on 27 Sept 2024

Earnings released on 28 Jun 2024

Earnings released on 19 Feb 2024

Earnings released on 9 Nov 2023

Earnings released on 28 Sept 2023

Earnings released on 19 Apr 2023

EPS came in at -$4.47 falling short of the estimated -$1.84 by -143.08%, while revenue for the quarter reached $2.44M .

Earnings released on 8 Apr 2023

EPS came in at -$2.28 falling short of the estimated -$1.84 by -24.08%, while revenue for the quarter reached $1.03M , missing expectations by -57.60%.

Stock split effective on 21 Dec 2022

Shares were split 1 : 12 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 30 Sept 2022

EPS came in at -$4.91 surpassing the estimated -$6.42 by +23.59%, while revenue for the quarter reached $1.25M , missing expectations by -55.72%.

Earnings released on 30 Jun 2022

EPS came in at -$6.42 surpassing the estimated -$7.80 by +17.67%, while revenue for the quarter reached $1.49M , missing expectations by -36.53%.

Earnings released on 31 Mar 2022

EPS came in at -$9.73 falling short of the estimated -$8.58 by -13.43%, while revenue for the quarter reached $1.18M , missing expectations by -44.91%.

Earnings released on 31 Dec 2021

EPS came in at -$8.24 , while revenue for the quarter reached $2.88M .

Earnings released on 30 Sept 2021

EPS came in at -$7.24 falling short of the estimated -$7.08 by -2.30%, while revenue for the quarter reached $2.52M , missing expectations by -14.08%.

Earnings released on 30 Jun 2021

EPS came in at -$4.69 , while revenue for the quarter reached $2.07M .

Earnings released on 31 Mar 2021

EPS came in at -$9.63 , while revenue for the quarter reached $1.44M .

Earnings released on 31 Dec 2020

EPS came in at -$9.95 , while revenue for the quarter reached $2.58M .

Stock split effective on 23 Nov 2020

Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 30 Sept 2020

EPS came in at -$13.47 , while revenue for the quarter reached $1.78M .

HTGMQ Stock Performance

Access detailed HTGMQ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run